Could a 4-Week radiation course be as good as 5 weeks for prostate cancer?

NCT ID NCT07483658

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study compares two radiotherapy schedules for men whose prostate cancer has returned after surgery. The standard treatment takes 5 weeks, while the shorter one takes 4 weeks. Researchers want to see if the shorter schedule causes no more side effects and controls the cancer just as well. About 434 men will take part, and the study will run for 12 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Radiotherapy (external beam radiation)
What this could lead to
If successful, this could offer men with recurrent prostate cancer a shorter, more convenient radiotherapy schedule with similar safety and cancer control.
What could go wrong
This is a non-inferiority trial, so the shorter schedule may prove less effective or cause different side effects. Results will take years, and the study is not yet recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Québec-Université Laval

    RECRUITING

    Québec, Quebec, G1G 5X1, Canada

  • Gatineau Hospital

    NOT_YET_RECRUITING

    Gatineau, Quebec, Canada

  • Hôpital Général Juif

    NOT_YET_RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

  • McGill University Health Centre

    NOT_YET_RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.